Leállították
Trial of Atezolizumab and Bevacizumab With CHS-388 or Placebo in Patients With Hepatocellular Carcinoma
NCT05359861· 2. fázis· Coherus Oncology, Inc.· Forrás
Lezárult
Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)
NCT03526250· 2. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Cisplatin/Carboplatin and Etoposide With or Without Nivolumab in Treating Patients With Extensive Stage Small Cell Lung Cancer
NCT03382561· 2. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Atezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery or Gallbladder Cancer
NCT03201458· 2. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Olaparib and Ramucirumab in Treating Patients With Metastatic or Locally Recurrent Gastric or Gastroesophageal Junction Cancer That Cannot Be Removed by Surgery
NCT03008278· 1/2. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Biospecimen Analysis in Determining Effects of Chemotherapy on Fertility in Osteosarcoma Survivors
NCT03206450· Children's Oncology Group· Forrás
Lezárult
Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)
NCT03213678· 2. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial)
NCT03213665· 2. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)
NCT03220035· 2. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Selumetinib Sulfate in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)
NCT03213691· 2. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)
NCT03233204· 2. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement
NCT02828358· 2. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer
NCT02844816· 2. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Carvedilol in Preventing Heart Failure in Childhood Cancer Survivors
NCT02717507· 2. fázis· Children's Oncology Group· Forrás
Lezárult
Denosumab in Treating Patients With Recurrent or Refractory Osteosarcoma
NCT02470091· 2. fázis· Children's Oncology Group· Forrás
Lezárult
Vemurafenib in Children With Recurrent/Refractory BRAF Gene V600E (BRAFV600E)-Mutant Gliomas
NCT01748149· Korai 1. fázis· University of California, San Francisco· Forrás
Lezárult
Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer
NCT02003209· 3. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma
NCT01979536· 2. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
NCT01798004· 1. fázis· Children's Oncology Group· Forrás
Lezárult
Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma
NCT01553149· 2. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors
NCT01602666· 2. fázis· Children's Oncology Group· Forrás
Lezárult
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery
NCT01013649· 3. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System
NCT00653068· 3. fázis· Children's Oncology Group· Forrás
Lezárult
Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
NCT00557193· 3. fázis· Children's Oncology Group· Forrás
Lezárult
Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma
NCT00336024· 3. fázis· Children's Oncology Group· Forrás
Lezárult
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
NCT00408005· 3. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Study of Kidney Tumors in Younger Patients
NCT00898365· Children's Oncology Group· Forrás
Lezárult
Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer Survivors
NCT00082745· Children's Oncology Group· Forrás
Lezárult
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
NCT00904241· Children's Oncology Group· Forrás